ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES

Project Information

IMMUTOL

Grant agreement ID: 101080562

DOI

10.3030/101080562

EC signature date 14 April 2023

Start date 1 May 2023

End date 30 April 2027

Funded under

• Health

Total cost

€ 5 999 340,00

EU contribution

€ 5 999 340,00

Coordinated by

FONDAZIONE TELETHON ETS
Italy

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (1)

External Advisory Board

Full appointment of the Advisory Board

Websites, patent fillings, videos etc. (1)

Set up Project website, project Logo

Implement the project website allowing project branding and visual identity

Publications

Peer reviewed articles (3)

Development Perspectives for Curative Technologies in Primary Demyelinating Disorders of the Central Nervous System with Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) at the Fore

Author(s): János György Pitter, László Nagy, Balázs Nagy, Rok Hren
Published in: Journal of Personalized Medicine, 2024, ISSN 2075-4426
Publisher: MDPI
DOI: 10.3390/jpm14060599

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

Author(s): Attila Imre, Balázs Nagy, Rok Hren
Published in: British Journal of Clinical Pharmacology, 2025, ISSN 0306-5251
Publisher: Wiley
DOI: 10.1002/BCP.70204

Leveraging current insights on <scp>IL</scp>‐10‐producing dendritic cells for developing effective immunotherapeutic approaches

Author(s): Konstantina Morali, Gloria Giacomello, Michela Vuono, Silvia Gregori
Published in: FEBS Letters, 2024, ISSN 0014-5793
Publisher: Wiley
DOI: 10.1002/1873-3468.15017